Halozyme Therapeutics Inc (HALO)

[Minninv]

From the call yesterday. First question. Helen is not sticking her neck out again by saying how many deals HALO will sign!!

Operator: [Operator Instructions] Your first question comes from the line of Jessica Fye with JPMorgan. Your line is open.

Jessica Phi: Hi, guys. Good afternoon. Thanks for taking my question. Just a couple here, I guess: first, what are your goals for signing new partnerships this year? And second, how quickly can you deploy the $750 million share repurchase authorization? Thank you.

Helen Torley: Thanks, Jess. I’ll take the first one. We certainly are off to a great start in 2024 with a robust set of meetings and forward momentum across all of our opportunities, that’s includes ENHANZE, the high volume auto-injector and the small-volume auto-injector. And our focus is on progressing all three of these types of deals. And we’re not putting a specific number on it, but we’re looking to advance all of these. And I look forward to updating you on that progress throughout the year. Nicole, will you tackle the question on the share repurchase new program?